Skip to main content
Top
Published in: Journal of Clinical Immunology 7/2014

01-10-2014 | Letter to Editor

“Good’s Syndrome Presenting with Recurrent Giardiasis”

Authors: Amit Rawat, Varun Dhir, Anju Gupta, Deepti Suri, Deepak K. Burad, Ritambra Nada, Surjit Singh

Published in: Journal of Clinical Immunology | Issue 7/2014

Login to get access

Excerpt

Good’s syndrome is an eponymous, acquired immunological disorder characterized by the association of immunodeficiency with thymoma. It was first described six decades ago in 1954. The pathogenesis of this enigmatic disorder is still not clear although mutations in the TACI and BAFF-R genes have recently been reported. A 53-year-old male presented at our hospital with a history of prolonged episodes of diarrhea since last 8 years. His first episode 8 years ago had lasted for one year. …
Metadata
Title
“Good’s Syndrome Presenting with Recurrent Giardiasis”
Authors
Amit Rawat
Varun Dhir
Anju Gupta
Deepti Suri
Deepak K. Burad
Ritambra Nada
Surjit Singh
Publication date
01-10-2014
Publisher
Springer US
Published in
Journal of Clinical Immunology / Issue 7/2014
Print ISSN: 0271-9142
Electronic ISSN: 1573-2592
DOI
https://doi.org/10.1007/s10875-014-0080-x

Other articles of this Issue 7/2014

Journal of Clinical Immunology 7/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.